IVERIC bio, Inc. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
IVERIC bio, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q1 2023.
  • IVERIC bio, Inc. Operating Lease, Payments for the quarter ending March 31, 2023 was $400K, a 33.3% increase year-over-year.
  • IVERIC bio, Inc. Operating Lease, Payments for the twelve months ending March 31, 2023 was $1.5M.
  • IVERIC bio, Inc. annual Operating Lease, Payments for 2022 was $1.4M, a 100% increase from 2021.
  • IVERIC bio, Inc. annual Operating Lease, Payments for 2021 was $700K, a 16.7% increase from 2020.
  • IVERIC bio, Inc. annual Operating Lease, Payments for 2020 was $600K, a 40% decline from 2019.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $1.5M $400K +$100K +33.3% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $1.4M $400K Oct 1, 2022 Dec 31, 2022 10-K 2023-03-01
Q3 2022 $500K Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-04
Q2 2022 $200K Apr 1, 2022 Jun 30, 2022 10-Q 2022-07-26
Q1 2022 $300K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2019 $1M $100K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-04
Q3 2019 $300K Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $300K Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $300K Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.